Modulation of key enzymes linked to Parkinsonism and neurologic disorders by Antiaris africana in rotenone-toxified rats

J Basic Clin Physiol Pharmacol. 2019 Dec 4;31(3):/j/jbcpp.2020.31.issue-3/jbcpp-2019-0014/jbcpp-2019-0014.xml. doi: 10.1515/jbcpp-2019-0014.

Abstract

Background The physiopathologies of many neurologic diseases are characterized by related biochemical dysfunctions that could be explored as drug targets. This study evaluated the effect of a methanol leaf extract of Antiaris africana (MEA) on critical bioindices of Parkinsonism and related neurologic dysfunctions in rats with rotenone-induced neurotoxicity. Methods Animals were administered 50 or 100 mg/kg MEA for 14 consecutive days. Rotenone (1.5 mg/kg) was administered three times per day on days 13 and 14. Coenzyme Q10 (5 mg/kg) was the reference drug. Complex I activity, dopamine level, activities of acetylcholinesterase, myeloperoxidase, Na+/K+ ATPase and glutamine synthetase, as well as oxidative stress indices were evaluated at the end of the period of treatment. Results Rotenone-intoxicated group showed disruption of complex 1 activity, dopamine level, and glutamine synthetase activity with negative alterations to activities of acetylcholinesterase, myeloperoxidase, and Na+/K+ ATPase as well as heightened cerebral oxidative stress. MEA restored brain mitochondria functionality, mitigated altered neurochemical integrity, and ameliorated cerebral oxidative stress occasioned by rotenone neurotoxicity. The activity of A. Africana was comparable with that of 5 mg/kg coenzyme Q10. Conclusions These results indicated that A. africana displayed therapeutic potential against Parkinsonism and related neurologic dysfunctions and support its ethnobotanical use for the treatment of neurologic disorders.

Keywords: Parkinsonism; mitochondrial dysfunction; neurologic disorders; neurotoxicity; phytomedicine.

MeSH terms

  • Acetylcholinesterase / metabolism
  • Animals
  • Antiaris / chemistry*
  • Dopamine / metabolism
  • Glutamate-Ammonia Ligase / metabolism
  • Male
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Nervous System Diseases / chemically induced
  • Nervous System Diseases / drug therapy*
  • Nervous System Diseases / metabolism
  • Neuroprotective Agents / pharmacology
  • Oxidative Stress / drug effects
  • Parkinsonian Disorders / chemically induced
  • Parkinsonian Disorders / drug therapy*
  • Parkinsonian Disorders / metabolism
  • Peroxidase / metabolism
  • Plant Extracts / pharmacology*
  • Rats
  • Rats, Wistar
  • Rotenone / pharmacology
  • Sodium-Potassium-Exchanging ATPase / metabolism
  • Ubiquinone / analogs & derivatives
  • Ubiquinone / metabolism

Substances

  • Neuroprotective Agents
  • Plant Extracts
  • Rotenone
  • Ubiquinone
  • Peroxidase
  • Acetylcholinesterase
  • Glutamate-Ammonia Ligase
  • Sodium-Potassium-Exchanging ATPase
  • coenzyme Q10
  • Dopamine